Mccamish Mark A.'s most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 11,000 Ordinary Shares done . Disclosure was reported to the exchange on July 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Pharmaceuticals plc... | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharmaceuticals plc... | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Rafael Holdings Inc - Ordi... | Mccamish Mark A. | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 60,241 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc - Ordi... | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 32,586 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc - Ordi... | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 05 Jan 2022 | 5,412 | 5,412 (0%) | 0% | 5.4 | 29,171 | Class B Common Stock, par value $.01 per share |
| Vincerx Pharma Inc | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 6,667 | 6,667 | - | - | Stock Option (right to buy) |